Sequenom News

Sequenom, Inc. , a life sciences company providing innovative genetic analysis solutions, today reported on a recently released publication in which the Sequenom MassARRAYA System was used in a groundbreaking independent study that detected the transforming fusion gene EML4 / ALK in non-small cell lung cancer .

SAN DIEGO, May 29, 2012 /PRNewswire via COMTEX/ -- Sequenom, Inc. , a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the Jefferies 2012 Global Healthcare Conference at the Grand Hyatt in New York, NY on June 4-7, 2012.

Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing.

SAN DIEGO, May 17, 2012 /PRNewswire/ -- Sequenom Inc., through its wholly owned subsidiary Sequenom Center for Molecular Medicine, LLC, entered into the recently announced provider network participation agreement with Coventry Health Care National Network, Inc.

I would now like to turn this conference over to Marcy Graham, Senior Director of Investor Relations.

SAN DIEGO, May 3, 2012 /PRNewswire/ -- Sequenom, Inc. , a life sciences company providing innovative genetic analysis solutions, today reported revenue of $14.9 million for the first quarter of 2012, an increase of 10% compared to revenue of $13.5 million for the first quarter of 2011.